Serial macro-architectural alterations with levodopa in Parkinson's disease: Polysomnography (PSG)-based analysis

Area of Science:

• Neurology
• Sleep Medicine
• Neuroscience

Background:

• Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
• Sleep disturbances are common in PD patients, even in early stages.
• The impact of levodopa on sleep macroarchitecture in drug-naïve PD patients requires further investigation.

Purpose of the Study:

• To investigate sleep macroarchitecture using polysomnography (PSG) in drug-naïve Parkinson's disease (PD) patients.
• To reassess sleep patterns after treatment with levodopa.

Main Methods:

• Prospective hospital-based study of 15 drug-naïve PD patients.
• Baseline assessment included demography, PD staging (Hoehn and Yahr), functional scales (Schwab and England ADL, UPDRS), and sleep questionnaires (ESS, PSQI, NIMHANS).
• Overnight PSG was performed at baseline and after approximately 13 months of levodopa treatment (440 mg/day).

Main Results:

• Levodopa improved UPDRS motor scores and reduced excessive daytime somnolence (P=0.04).
• Mean oxygen saturation during sleep significantly improved (P=0.002), and periodic leg movements (PLMs) reduced.
• Sleep efficiency, sleep onset latency, and stage 1 sleep duration increased, while 'awake in bed', slow wave sleep, and REM sleep duration decreased. Snore index increased (P<0.03).

Conclusions:

• Sleep alterations are present in early-stage Parkinson's disease due to the disease process itself.
• Levodopa treatment demonstrated improvements in several sleep macroarchitecture parameters, including daytime somnolence and oxygen saturation.